Exclusive | Pharma Industry moves drug controller to ease new export guidelines
India’s pharmaceutical industry is urging the DCGI to ease new export norms, which it claims are delaying $3 billion in annual trade. Under the revised rules, exporters must secure regulatory approval from importing nations—an impractical requirement for many markets. The DCGI maintains the changes improve oversight and align with global standards.

What's Your Reaction?






